Compound Detail
CHEMBL5416478
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5416478 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JVKPYNWCJWBPHL-CAOOACKPSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
356.3
MW (Da)
1.67
ALogP
7
HBA
0
HBD
126.3
PSA (Ų)
0.25
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 7.14
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Caco-2 | IC50 | = | 73.0 | nM | 7.14 | Anticancer activity against human Caco-2 cells incubated for 72 hrs by MTT assay | 36921275 |
| MCF7 | IC50 | = | 76.0 | nM | 7.12 | Anticancer activity against human MCF7 cells incubated for 72 hrs by MTT assay | 36921275 |
| WI-38 | IC50 | = | 226.0 | nM | 6.65 | Cytotoxicity in human WI-38 cells assessed as reduction in cell viability incuba... | 36921275 |
| HepG2 | IC50 | = | 277.0 | nM | 6.56 | Anticancer activity against human HepG2 cells incubated for 72 hrs by MTT assay | 36921275 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36921275 | 10.1021/acs.jmedchem.2c01408 | WI-38 | 2 |
| 36921275 | 10.1021/acs.jmedchem.2c01408 | MCF7 | 2 |
| 36921275 | 10.1021/acs.jmedchem.2c01408 | ADMET | 2 |
| 36921275 | 10.1021/acs.jmedchem.2c01408 | Caco-2 | 1 |
| 36921275 | 10.1021/acs.jmedchem.2c01408 | Unchecked | 1 |
| 36921275 | 10.1021/acs.jmedchem.2c01408 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine